Poor ten year prognosis for her2 t1No ....

[RobinP]

Well I read the article I was waiting for from the San Antonio Breast Conference abstracts that was just released today. According to it, the ten year prognosis is much lowered for her2 early stage bc. Yet, we must remember the cohort that was researched was from years ago when adjuvant Herceptin was not used and adjuvant chemotherapy may not have been recommended either for such small and early breast cancer. Additionally, the her2+. hormonal negative test group was very small at n= 42. I would say that is too small of a group to have statistical significance and that more studies are indicated. At the same time, I feel the study does suggest the need for aggressive chemotherapy and Herceptin for early stage her2+, hormonal negative breast cancer.For those interestsed the abstract I am regarding, is 2031 on the San Antonio Breast site.